SNFGE SNFGE
 
Thématique :
- Carcinome hépatocellulaire (CHC)
Originalité :
Intermédiaire
Solidité :
Très solide
Doit faire évoluer notre pratique :
Pas encore
 
 
Nom du veilleur :
Professeur Sylvain MANFREDI
Coup de coeur :
 
 
Digestive and Liver Disease
  2018/04  
 
  2018 Apr;50(4):401-407.  
  doi: 10.1016/j.dld.2017.11.003.  
 
  Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature  
 
  Dong Y, Teufel A, Trojan J, Berzigotti A, Cui XW, Dietrich CF  
  https://www.ncbi.nlm.nih.gov/pubmed/29233685  
 
 

Abstract

BACKGROUND:

Mixed hepatocellular cholangiocarcinoma is a rare form of primary liver cancer.

AIMS:

The aim of this study is to report the results of the use of contrast enhanced ultrasound in a series of patients with confirmed mixed hepatocellular cholangiocarcinoma and to provide an updated literature review.

METHODS:

Between January 2012 and October 2016, 25 Asian patients with confirmed mixed hepatocellular cholangiocarcinoma were included in this bicentric retrospective analysis. Clinical data as well recorded images of a standardized conventional B-mode ultrasound and contrast-enhanced ultrasound examination were interpreted by two blinded, independent, experienced radiologists in consensus.

RESULTS:

All mixed hepatocellular cholangiocarcinoma lesions were heteroechoic on B-mode ultrasound, with ill-defined margins and irregular shapes. Arterial phase hyperenhancement was present in all 25 patients. Late-phase washout and hypoenhancement was present in 24/25 (96%) patients. However, rim-enhancement and early wash-out (which are common in cholangiocellular carcinoma) were found in over 60% of the cases.

CONCLUSION:

Contrast-enhanced ultrasound demonstrated findings not typical for HCC in a large proportion of patients with confirmed mixed hepatocellular cholangiocarcinoma. Therefore, histological confirmation is crucial, especially in lesions with atypical findings.

 

 
Question posée
 
Est-ce que l’échographie de contraste peut différencier les CHC des hépato-cholangiocarcinomes ?
 
Question posée
 
Malgré des différences de comportements vasculaires en échographie de contraste, l’écho de contraste ne permet pas de se passer de la biopsie.
 
Commentaires

-

 
www.snfge.org